11ª Aula: Ansiedade, Saúde Mental e a Cannabis sativa L. - Professor Wilson Lessa
New Section
In this section, the instructor welcomes the viewers to the lesson and provides an overview of what will be covered. They also mention that most of the questions asked by viewers have been answered in a short orientation video.
Introduction and Orientation
- The instructor welcomes everyone to the lesson and mentions that it is the 10th lesson of the course.
- They remind viewers about a previous video where they presented the team and discussed current events related to the course.
- Most of the questions asked by viewers have been answered in a short orientation video.
- The orientation video is available on YouTube along with all other videos from this edition and previous editions of the course.
New Section
In this section, the instructor talks about accessing class materials and addresses common doubts regarding formulas used in the course.
Accessing Class Materials and Formulas
- All videos from this edition are available on a playlist on YouTube.
- Viewers can access class materials, including formulas, through links provided in the video descriptions.
- To confirm attendance or send presence, viewers can click on a link provided in green text within the description of each video.
- There may have been some errors with confirmation settings in previous classes, but they have been corrected. Viewers can send their confirmation multiple times if needed.
New Section
In this section, Dr. Wilson Lesson joins as a guest speaker to discuss cannabis use for anxiety and psychiatric cases.
Guest Speaker: Dr. Wilson Lesson - Cannabis for Anxiety
- Dr. Wilson Lesson, a psychiatrist, will talk about using cannabis for anxiety and psychiatric cases.
- This is an opportunity to hear from Dr. Wilson Lesson during this course.
New Section
In this section, Dr. Wilson Lesson introduces himself and discusses the relationship between mental health, cannabis, and therapeutic conditions.
Introduction to Mental Health and Cannabis
- Dr. Wilson Lesson is a psychiatrist and professor at the University of Federal Daparaiban.
- He teaches psychiatry in the medicine course and the system of cannabis in biomedicine.
- Cannabis can play a role in mental health and therapeutic conditions.
- The use of cannabis will be explored further in the course.
New Section
In this section, Dr. Wilson Lesson mentions a medication called Rimonavanto that was released in Brazil but later withdrawn due to serious side effects.
Medication: Rimonavanto
- Rimonavanto was a medication released in Brazil in 2007.
- It was intended to reduce appetite and body fat as an obesity treatment.
- However, it caused serious side effects related to the central nervous system, including anxiety, panic, depression, and even cases of suicide.
- Due to these severe collateral effects, pharmacies stopped selling Rimonavanto.
Timestamps are provided for each section based on available information from the transcript.
New Section
This section discusses the functions of the Cp1 system and its role in relaxation, sleep, and anxiety control.
Functions of the Cp1 System
- The Cp1 system has five main functions: relaxation, protection, eating, sleeping, and forgetting.
- Research conducted in 1998 by Marzo Viscenzo hypothesized these functions.
New Section
This section explores the effects of antagonizing the Cp1 cannabinoid receptor and a case study involving a deficiency in an enzyme related to cannabinoids.
Effects of Antagonizing the Cp1 Receptor
- Antagonizing the Cp1 cannabinoid receptor can lead to an anti-analytic effect and a decrease in naturalness within the cannabinoid system.
Case Study: Deficiency in Enzyme Production
- A woman discovered she had a deficiency in an enzyme responsible for degrading cannabinoids during surgery. She did not feel pain and did not require analgesic medications afterward.
- Further research revealed that this deficiency also resulted in a lack of physiological reactions to anxiety.
- The woman's husband confirmed her lack of pain perception and anxiety reactions.
New Section
This section highlights how deficiencies or modulations within the cannabinoid system can affect pain perception, anxiety reactions, and hormonal balance.
Modulation within the Cannabinoid System
- Deficiencies or modulations within the cannabinoid system can result in individuals not feeling pain or experiencing physiological reactions to anxiety.
- Such modulations may have implications for various diseases related to anxiety and pain.
New Section
This section discusses a study conducted in 2021 that evaluated the efficacy and safety of cannabinoids in reducing anxiety symptoms among health professionals during the COVID-19 period.
Study on Cannabinoids and Anxiety Symptoms
- A study conducted at the University of Uspi in 2020 compared the effects of cannabinoids with a placebo on anxiety symptoms among health professionals.
- The results showed a significant reduction of 60% in anxiety symptoms, 50% in depression symptoms, and 25% in burnout among those who received cannabinoid treatment compared to those who only received standard treatment.
- The study analyzed data after 14 and 28 days of pharmacok use with modified higher dosages.
New Section
This section explores the impact of excessive or chronic anxiety and its classification within different trans-sounds categories.
Excessive or Chronic Anxiety
- Excessive or chronic anxiety can result in up to 10,000 mental trans-sounds.
- Anxiety disorders such as social anxiety and post-traumatic stress disorder are classified within different trans-sounds categories.
New Section
This section discusses the treatment options for trans-sounds, focusing on therapy and medication.
Treatment Options for Trans-sounds
- The primary treatment for trans-sounds is therapy, often combined with medication. Cognitive-behavioral therapy is commonly used.
- Medications such as serotonin inhibitors, noradrenaline reuptake inhibitors, vaccines, ocetina, pre-gabapentin, psychlics, bospirona, moclobemide, and benzodiazepines are also used.
New Section
This section highlights the challenges faced by patients in adhering to treatment for trans-sounds.
Challenges in Treatment Adherence
- Approximately 40% of patients continue to experience residual symptoms or face difficulties accessing and adhering to treatment.
New Section
This section discusses the various effects and side effects of antidepressants, including sexual dysfunction, difficulty organizing, cognitive impairment, and psychomotor issues.
Effects of Antidepressants
- Antidepressants can cause sexual dysfunction, difficulty organizing, and cognitive and psychomotor impairments.
- Benzodiazepines and pregabalin can also lead to insomnia and weight gain as side effects.
- New treatments or adjunctive therapies may be needed to address these side effects.
New Section
This section explores the impact of cannabinoids on emotional regulation and behavior.
Cannabinoids and Emotional Behavior
- The activation of the C-1 receptor by cannabinoids like THC plays a critical role in regulating body systems' response to stress.
- Recent studies suggest that enhancing endocannabinoid signaling may be promising for treating stress-related disorders.
New Section
This section focuses on the relationship between cannabis use and anxiety.
Cannabis Use and Anxiety
- Low doses of THC in cannabis have been found to reduce anxiety and promote relaxation.
- Initial cannabis use is associated with a reduction in anxiety symptoms, but chronic use can worsen anxiety, leading to panic attacks.
- The THC content in cannabis plays a significant role in its impact on anxiety symptoms. Higher THC doses can increase anxiety levels.
- Patients who switch from low THC content cannabis to high THC content cannabis may experience increased anxiety symptoms.
New Section
This section discusses the impact of THC dosage on anxiety.
THC Dosage and Anxiety
- Low doses of THC have anti-anxiety effects, while chronic administration of high THC doses can increase anxiety.
- The dosage threshold for low, moderate, and high THC doses is typically defined as follows: up to 7mg (low), 7-18mg (moderate), and above 18mg (high).
- Different individuals may have varying responses to different THC dosages, so it's important to consider individual tolerance levels.
The transcript provided does not include any timestamps beyond this point.
New Section
This section discusses the effects of the sedative elimination of the receptor C-B1 in glutamate neurons and its relationship to cannabinoids.
Activation of C-B1 Receptor in Glutamate Neurons
- The sedative elimination of the receptor C-B1 in glutamate neurons causes a decrease in neurotransmitter elimination.
- Activation of the C-B1 receptor in glutamate neurons leads to an ephetanciogenic effect by high doses of THC.
- Higher doses of THC activate the C-B1 receptor in inhibitory caabaedic neurons, resulting in anxiety.
Safety and Effects of Caabaedial
- Caabaedial has been tested up to 1500 mg per day without negative effects or sedation.
- It has an ephetanciolithic effect and interacts with various receptors, including 5-H-T-1-A and C-B-1 receptors.
- CBD exposure shows potential for treating anxiety symptoms without causing tolerance or loss of effect over time.
Preclinical Evidence and Human Studies
- Preclinical evidence supports CBD's potential as a treatment for anxiety and post-traumatic stress disorder.
- Systematic reviews show that purified caabaedial is safe and well-tolerated in humans.
- Patients using moderate THC intermittently report positive results, suggesting its importance for future research.
Tolerance Reduction Strategies
- To decrease tolerance, patients can do therapy sessions where they abstain from THC use one day per week.
- Negative features between THC consumption can be reduced by using specific dosing strategies.
- Delta TTHC outputs have shown improvement in decreasing anxiety and panic attacks without sedation.
Importance of Terpenes
- Terpenes, essential oils, have sedative effects and should be considered in research for these cases.
The summary has been provided in English as per the given instructions.
New Section
This section discusses the use of cannabis in mental health, specifically its potential for treating conditions such as anxiety and stress.
Cannabis and Memory Enhancement
- Research suggests that cannabis may have a positive impact on memory enhancement and fixation.
- A systematic review conducted in 2017 found that cannabis has potential for treating gastroamatic stress and substance use disorders.
- However, more research is needed to fully understand the effects of medicinal cannabis on mental health.
New Section
This section explores a systematic review conducted in 2017 regarding the use of cannabis in mental health.
Findings from Systematic Review
- The systematic review highlighted that mental health conditions are prevalent among users of medicinal cannabis.
- Cannabis showed potential for treating gastroamatic stress and substance use disorders.
- It was noted that further research is necessary to fully understand the impacts of medicinal cannabis on mental health.
New Section
This section discusses interesting studies related to the spectrum of psychiatric disorders and anxiety, as well as recent work by Dr. Stacey Gruber on low-dose CBD treatment.
Studies on Psychiatric Disorders and Anxiety
- Previous studies have explored the relationship between psychiatric disorders, anxiety, and the spectrum of psychiatric diseases.
- Recent work by Dr. Stacey Gruber focused on low-dose CBD treatment for individuals with high-density concentration generalization.
- Basic strategies for anxiety management include low-dose or moderate CBD intake two to three times a day.
New Section
This section emphasizes the importance of finding an optimal dosage for patients using cannabinoids to treat anxiety.
Finding Optimal Dosage
- It is recommended to start with a low-dose CBD regimen and gradually increase until the patient finds a dosage that works well for them.
- Research is ongoing to determine the impacts of different CBD dosages on anxiety and mental health.
- Some individuals may be more sensitive to high-dose CBD and may require lower doses for effective treatment.
New Section
This section explores treatment strategies for anxiety, including the use of high-dose CBD or isolated cannabinoids.
Treatment Strategies for Anxiety
- For patients who desire to use cannabinoids to decrease anxiety, a tentative approach with high-dose CBD or isolated cannabinoids (10-200 milligrams) two to three times a day can be considered.
- It is important to consider individual differences in genetic polymorphism and metabolization when determining the appropriate dosage.
- The spectrum of high-density CBD (2%-3%) or broad-spectrum CBD with all components except THC can also be effective in treating anxiety.
New Section
This section discusses strategies for managing anxiety and decreasing epinephrine levels using cannabinoids.
Managing Anxiety and Epinephrine Levels
- Cannabinoids can help decrease epinephrine levels, which contributes to anxiety symptoms.
- Gradually reducing the dosage of cannabinoids over time can be an effective strategy for minimizing withdrawal symptoms.
- Patients with higher autonomy and self-control have a better chance of success in treating anxiety with cannabinoids, while those with low autonomy may require closer monitoring.
New Section
This section highlights the importance of studying the effects of diminishing epinephrine levels strategically when using cannabinoids.
Diminishing Epinephrine Levels
- There is a need for further research on strategic approaches to diminish epinephrine levels when using cannabinoids.
- Abruptly discontinuing cannabinoid use after prolonged high-dose intake can lead to withdrawal symptoms.
- Careful consideration should be given to the duration and combination of medications used alongside cannabinoids.
New Section
This section emphasizes the importance of studying the effects of diminishing epinephrine levels strategically when using cannabinoids.
Diminishing Epinephrine Levels
- There is a need for further research on strategic approaches to diminish epinephrine levels when using cannabinoids.
- Abruptly discontinuing cannabinoid use after prolonged high-dose intake can lead to withdrawal symptoms.
- Careful consideration should be given to the duration and combination of medications used alongside cannabinoids.
New Section
This section discusses the prolonged use of high-density cannabinoids and their impact on tolerance.
Prolonged Use of High-Density Cannabinoids
- Prolonged use of high-density cannabinoids can lead to tolerance, reducing their effectiveness over time.
- THC, a sub-cannabinoid, may initially improve anxiety symptoms but can increase anxiety during periods without cannabinoid intake.
- Patients with higher autonomy and self-control have a better chance of success in treating anxiety with cannabinoids.
New Section
This section highlights the importance of individual characteristics in determining treatment success with cannabinoids for anxiety.
Individual Characteristics and Treatment Success
- Patients with higher autonomy and self-control are more likely to succeed in treating anxiety with cannabinoids.
- Patients with low autonomy, high failure rates, and a history of substance abuse require closer monitoring during treatment.
- Further research is needed to explore strategies for diminishing epinephrine levels strategically when using cannabinoids.
New Section
This section discusses strategies for managing anxiety through the use of different types and dosages of CBD.
Managing Anxiety with CBD
- The spectrum of high-density CBD, containing at least 2%-3% CBD, or isolated CBD can be effective in managing anxiety.
- Dosages between 10 to 50 milligrams per day are commonly used for anxiety management.
- Individual preferences and the specific symptoms being targeted should be considered when determining the optimal dosage.
New Section
This section explores the potential benefits and risks of using cannabinoids to decrease epinephrine levels.
Decreasing Epinephrine Levels with Cannabinoids
- Cannabinoids can help decrease epinephrine levels, which may alleviate anxiety symptoms.
- However, there is a possibility of increased physical and ascending effects with cannabinoid use.
- Gradually reducing the dosage by 25% each week can be an effective strategy for minimizing withdrawal symptoms when discontinuing cannabinoids.
New Section
This section emphasizes the importance of gradually reducing cannabinoid intake to minimize withdrawal symptoms.
Gradual Reduction of Cannabinoid Intake
- Gradually reducing cannabinoid intake by 25% each week can help minimize withdrawal symptoms.
- Prolonged use of high-density cannabinoids can lead to tolerance and increased probability of anxiety symptoms during periods without cannabinoid intake.
- Patients with higher autonomy and self-control have a better chance of success in treating anxiety with cannabinoids.
New Section
This section discusses the prolonged use of high-density cannabinoids and its impact on tolerance.
Prolonged Use of High-Density Cannabinoids
- Prolonged use of high-density cannabinoids can lead to tolerance, reducing their effectiveness over time.
- THC, a sub-cannabinoid, may initially improve anxiety symptoms but can increase anxiety during periods without cannabinoid intake.
- Patients with higher autonomy and self-control have a better chance of success in treating anxiety with cannabinoids.
New Section
This section emphasizes the importance of individual characteristics and monitoring when using cannabinoids for anxiety treatment.
Individual Characteristics and Monitoring
- Patients with higher autonomy and self-control are more likely to succeed in treating anxiety with cannabinoids.
- Patients with low autonomy, high failure rates, and a history of substance abuse require closer monitoring during treatment.
- Further research is needed to explore strategies for diminishing epinephrine levels strategically when using cannabinoids.
New Section
This section highlights the potential benefits and risks of using cannabinoids to decrease epinephrine levels.
Decreasing Epinephrine Levels with Cannabinoids
- Cannabinoids can help decrease epinephrine levels, which may alleviate anxiety symptoms.
- However, prolonged use of high-dose cannabinoids can be challenging when combined with other long-term antidepressant medications.
- Further research is needed to develop strategic approaches for using cannabinoids to diminish epinephrine levels effectively.